Stocks
195854CRME
YHDHealthcareBiotechnology
A clinical-stage biopharmaceutical company developing therapies for rare genetic diseases, with a focus on gene therapy and enzyme replacement approaches. Its lead programs target lysosomal storage disorders, and investors track it for its pipeline milestones and potential regulatory approvals.
Congressional Interest in 195854 (CRME)
1 member of Congress has disclosed 1 trade in 195854 (CRME), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
1
Sells
0
Who in Congress Is Trading CRME?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-01-15 | JAMES B. RENACCI | buy | $1K-$15K |